Saftaz 1.125 Injection
Marketer
Louies Life Sciences
Salt Composition
Cefoperazone (1000mg) + Tazobactum (125mg)
Overview Saftaz 1.125 Injection
Ceftazidime/Sulbactam 1.125g Injection is a dual-action antibiotic indicated for diverse bacterial infections. Its mechanism combats microbial proliferation, thus curbing infection spread. Administration must be solely under medical guidance. Complete the prescribed regimen, regardless of symptom improvement; premature cessation can compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms necessitate immediate medical attention. Seek immediate help for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your physician of all concurrent medications, including those for pre-existing conditions. Pregnant or lactating individuals should consult their doctor before use. Alcohol should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, avoid driving if drowsiness or dizziness occur. Adequate rest, nutrition, and hydration are crucial for optimal recovery. Monitoring may involve laboratory tests to assess treatment effectiveness.
Primary Ingredients of Saftaz 1.125 Injection
There is no text provided to rephrase.
Uses of Saftaz 1.125 Injection
Managing bacterial infections
Major Benefits of Saftaz 1.125 Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Saftaz 1.125 Injection:
- Diarrhea
- Abnormal liver function tests
- Allergic reaction
- Anemia (low number of red blood cells)
How to use Saftaz 1.125 Injection:
Administering this medication will be performed by your doctor or nurse; self-medication is strictly prohibited.
How Saftaz 1.125 Injection works:
Saftaz 1.125 Injection combines Cefoperazone, a bacterial cell wall synthesis inhibitor, and Tazobactum, a beta-lactamase inhibitor. Cefoperazone's antibiotic action disrupts bacterial defenses, crucial for their viability. Tazobactum counteracts bacterial resistance mechanisms, boosting Cefoperazone's effectiveness.
SAFETY ADVICE
AlcoholUNSAFE
Ingestion of alcohol during Saftaz 1.125 Injection treatment can trigger adverse effects including facial flushing, tachycardia, nausea, thirst, chest discomfort, and hypotension (a disulfiram-like response).
PregnancySAFE IF PRESCRIBED
Ceftazidime 1.125 gram injection is typically deemed safe for use in pregnant individuals. Preclinical trials using animal models revealed minimal or no negative consequences for fetal development; nevertheless, clinical data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can generally use Saftaz 1.125 Injection without safety concerns. Research in humans indicates minimal drug transfer into breast milk, posing no known risk to the infant.
DrivingCONSULT YOUR DOCTOR
Saftaz 1.125 Injection's effect on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Saftaz 1.125 Injection administration to individuals with renal impairment. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding Saftaz 1.125 Injection's use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Saftaz 1.125 Injection :
Omit a Saftaz 1.125 Injection dose? Seek medical advice immediately.
Facts to Know About Saftaz 1.125 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently